The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-methoxy-6-pentadecylcyclohexa-2,5-diene-1,4-dione ID: ALA4550999
Cas Number: 144078-11-5
PubChem CID: 71345494
Max Phase: Preclinical
Molecular Formula: C22H36O3
Molecular Weight: 348.53
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCCCCCCCC1=CC(=O)C=C(OC)C1=O
Standard InChI: InChI=1S/C22H36O3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-17-20(23)18-21(25-2)22(19)24/h17-18H,3-16H2,1-2H3
Standard InChI Key: MQOUTWWGQSEUCT-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 25 0 0 0 0 0 0 0 0999 V2000
2.4598 -9.7692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4598 -10.5905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1692 -10.9949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8786 -10.5905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8786 -9.7692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1692 -9.3523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7468 -9.3585 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7444 -8.5372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1692 -8.5310 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1692 -11.8163 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5917 -9.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3023 -9.7733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0112 -9.3626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7218 -9.7774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4349 -9.3668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1455 -9.7816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1431 -10.6029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8538 -11.0136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8514 -11.8349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5620 -12.2497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5596 -13.0710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8466 -13.4775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1359 -13.0669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4229 -13.4734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7123 -13.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
1 7 1 0
7 8 1 0
6 9 2 0
3 10 2 0
5 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 348.53Molecular Weight (Monoisotopic): 348.2664AlogP: 6.08#Rotatable Bonds: 15Polar Surface Area: 43.37Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 7.24CX LogD: 7.24Aromatic Rings: ┄Heavy Atoms: 25QED Weighted: 0.27Np Likeness Score: 1.33
References 1. Xu X, Meng Y, Li L, Xu P, Wang J, Li Z, Bian J.. (2019) Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions., 62 (3): [PMID:30148361 ] [10.1021/acs.jmedchem.8b00961 ] 2. Sisa M,Dvorakova M,Temml V,Jarosova V,Vanek T,Landa P. (2020) Synthesis, inhibitory activity and in silico docking of dual COX/5-LOX inhibitors with quinone and resorcinol core., 204 [PMID:32738413 ] [10.1016/j.ejmech.2020.112620 ]